As a healthcare provider we allowed to serve our existing patients as well as anyone else who may have symptoms that suggest heart disease. We have safeguarded both our patients and staff against infection from Coronavirus whilst still providing the consultations and diagnostics.
Our cardiologists are at the cutting edge of their fields of interest. They are active researchers and are asked to lecture locally and internationally. See below for a selection of their research:
Lancet. 2021 Jan 30;397(10272):371-372. doi: 10.1016/S0140-6736(20)32393-X.
Perfusion. 2021 Jan 9:267659120986532. doi: 10.1177/0267659120986532.
Front Cardiovasc Med. 2020 Nov 13;7:591946. doi: 10.3389/fcvm.2020.591946.
Interv Cardiol. 2020 Nov 24;15:e16. doi: 10.15420/icr.2020.21.
Comparison of the self-expanding Evolut-PRO transcatheter aortic valve to its predecessor Evolut-R in the real world multicenter ATLAS registry.
Int J Cardiol. 2020 Jul 1;310:120-125. doi: 10.1016/j.ijcard.2020.02.070. Epub 2020 Feb 27.
Outcome of inter-hospital transfer versus direct admission for primary percutaneous coronary intervention: An observational study of 25,315 patients with ST-elevation myocardial infarction from the London Heart Attack Group.
Eur Heart J Acute Cardiovasc Care. 2020 Mar 20:2048872619882340. doi: 10.1177/2048872619882340. Online ahead of print.